Molecular firm Qiagen releases rapid H1N1 test

China has a hunger for new technologies and ways to improve people's lives, which in turn provides huge incentive to innovation-driven companies, a leader from molecular analysis firm Qiagen said yesterday at the Summer Davos forum in Dalian.

Victor Shi, president of Qiagen Asia, said that Qiagen's business in China has been outpacing the country's GDP growth since it started an operation in Shanghai in 2006.

One of its latest projects has been cooperation in the prevention and control of H1N1 influenza, Shi said, in which Qiagen has worked closely with the Chinese Center for Disease Control and Prevention to provide a quick and accurate test.